image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

S4 Capital - Shares hit new high of 872p

November 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SFOR
  • Price:
  • 772p
A terrific month for the shares of S4, which zoomed to a new high of 872p. The catalyst for the move was the acquisition of Zemoga, which provides tech and digital transformation services and has offices in LA, New York, Connecticut and Columbia and effectively starts a new vertical market for S4. Zemoga serves sectors such as Over The Top (OTT) / TVE, Fintech, Health and Retail.As usual, CEO Sir Martin Sorrell has provided little detail aside from the fact that Zemoga employs 400 tech specialists (heavily skewed to Columbia) and has achieved four-year compound annual revenue growth of 45% p.a.Earlier in the month, S4 announced interims showing like-for-like gross profit rising 91% to £236.7m, driven by a doubling of he ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X